THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Voltage‐gated ion channels

The Concise Guide to PHARMACOLOGY 2017/18 provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point‐in‐time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.13884/full. Voltage‐gated ion channels are one of the eight major pharmacological targets into which the Guide is divided, with the others being: G protein‐coupled receptors, ligand‐gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid‐2017, and supersedes data presented in the 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature Committee of the Union of Basic and Clinical Pharmacology (NC‐IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.

[1]  B. Chizh,et al.  Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway. , 2009, Drug discovery today.

[2]  Simon Markus Beck Nutzungsherausgabe bei kaufrechtlicher Ersatzlieferung , 2006 .

[3]  D. Jenkinson,et al.  Potassium channels – multiplicity and challenges , 2006, British journal of pharmacology.

[4]  K. Iwata,et al.  Potassium channels as a potential therapeutic target for trigeminal neuropathic and inflammatory pain , 2011, Molecular pain.

[5]  Dietmar Krautwurst,et al.  Synthetic modulators of TRP channel activity. , 2011, Advances in experimental medicine and biology.

[6]  S. Olesen,et al.  BK channel modulators: a comprehensive overview. , 2008, Current medicinal chemistry.

[7]  Gerasimos S Filippatos,et al.  Drug-induced long QT syndrome. , 2007, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[8]  D. Bayliss,et al.  International Union of Pharmacology. LV. Nomenclature and Molecular Relationships of Two-P Potassium Channels , 2005, Pharmacological Reviews.

[9]  Nobuaki Takahashi,et al.  Chemical physiology of oxidative stress-activated TRPM2 and TRPC5 channels. , 2010, Progress in biophysics and molecular biology.

[10]  Ayako Matsuyama,et al.  Voltage-gated sodium channels and pain-related disorders. , 2016, Clinical science.

[11]  W. N. Zagotta,et al.  CNG and HCN channels: two peas, one pod. , 2006, Annual review of physiology.

[12]  Poul Behrendt Søren Kierkegaard’s Fortnight , 2004 .

[13]  Shoji Hara,et al.  A practical synthetic method of Iodoarene difluorides without fluorine gas and mercury salts , 2002 .

[14]  P. Bois,et al.  Molecular regulation and pharmacology of pacemaker channels. , 2007, Current pharmaceutical design.

[15]  Alexander Zholos,et al.  Pharmacology of transient receptor potential melastatin channels in the vasculature , 2010, British journal of pharmacology.

[16]  Craig Montell,et al.  International Union of Pharmacology. XLIII. Compendium of Voltage-Gated Ion Channels: Transient Receptor Potential Channels , 2003, Pharmacological Reviews.

[17]  Harry J Witchel,et al.  The hERG potassium channel as a therapeutic target , 2007, Expert opinion on therapeutic targets.

[18]  M. Stocker Ca2+-activated K+ channels: molecular determinants and function of the SK family , 2004, Nature Reviews Neuroscience.

[19]  A. Wickenden,et al.  Kv7 channels as targets for the treatment of pain. , 2009, Current pharmaceutical design.

[20]  Stefan Heller,et al.  TRP Channel Trafficking -- TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades , 2007 .

[21]  D. Vasilyev,et al.  Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels and pain. , 2009, Current pharmaceutical design.

[22]  Martin Biel,et al.  International Union of Pharmacology. LI. Nomenclature and Structure-Function Relationships of Cyclic Nucleotide-Regulated Channels , 2005, Pharmacological Reviews.

[23]  K. S. James,et al.  Indian Parish Records : A qualitative assessment , 2000 .

[24]  Bernd Nilius,et al.  Transient receptor potential channelopathies , 2010, Pflügers Archiv - European Journal of Physiology.

[25]  Christopher A Ahern,et al.  Chemical tools for K(+) channel biology. , 2009, Biochemistry.

[26]  Osvaldo Alvarez,et al.  Molecular Determinants of BK Channel Functional Diversity and Functioning. , 2017, Physiological reviews.

[27]  Charles R Sanders,et al.  Regulation of KCNQ/Kv7 family voltage-gated K+ channels by lipids. , 2017, Biochimica et biophysica acta. Biomembranes.

[28]  M. Gollasch,et al.  Pharmacological Modulation of Diacylglycerol-Sensitive TRPC3/6/7 Channels , 2011, Current pharmaceutical biotechnology.

[29]  Louis V. Gerstner Question time: organizational shake-ups , 2000, UBIQ.

[30]  B. Bean The action potential in mammalian central neurons , 2007, Nature Reviews Neuroscience.

[31]  D. Bayliss,et al.  Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact. , 2008, Trends in pharmacological sciences.

[32]  Jules C Hancox,et al.  The hERG potassium channel and hERG screening for drug-induced torsades de pointes. , 2008, Pharmacology & therapeutics.

[33]  D. Clapham,et al.  An introduction to TRP channels. , 2006, Annual review of physiology.

[34]  William A Catterall,et al.  The chemical basis for electrical signaling. , 2017, Nature chemical biology.

[35]  K. Rhodes,et al.  Localization of voltage-gated ion channels in mammalian brain. , 2004, Annual review of physiology.

[36]  Rafał Kaczmarek,et al.  Quality Assessment of Welded Joints Using TOFD Technique in View of Requirements of Current Standards , 2017 .

[37]  Francesco Altomare,et al.  POSITIVE OPERATORS AND APPROXIMATION IN FUNCTION SPACES ON COMPLETELY REGULAR SPACES , 2003 .

[38]  W. González,et al.  Gating, Regulation, and Structure in K2P K+ Channels: In Varietate Concordia? , 2016, Molecular Pharmacology.

[39]  Jayprakash Ninu Chaudhari,et al.  On Exact Sequence of Semimodules over Semirings , 2013 .

[40]  Irina Vetter,et al.  The pharmacology of voltage-gated sodium channel activators , 2017, Neuropharmacology.

[41]  Marc Fellous,et al.  Genetic male infertility and mutation of CATSPER ion channels , 2010, European Journal of Human Genetics.

[42]  S. Olesen,et al.  K(v)7 channels: function, pharmacology and channel modulators. , 2006, Current topics in medicinal chemistry.

[43]  Yuriy Kirichok,et al.  Rediscovering sperm ion channels with the patch-clamp technique. , 2011, Molecular human reproduction.

[44]  B. Rudy,et al.  International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium Channels , 2005, Pharmacological Reviews.

[45]  Annalisa Bucchi,et al.  Physiology and pharmacology of the cardiac pacemaker ("funny") current. , 2005, Pharmacology & therapeutics.

[46]  P. McNaughton,et al.  The thermo‐TRP ion channel family: properties and therapeutic implications , 2012, British journal of pharmacology.

[47]  Péter Enyedi,et al.  Molecular Background of Leak K (cid:1) Currents: Two-Pore Domain Potassium Channels , 2010 .

[48]  Michio Inagaki New Development in Alkali Metal-Graphite Intercalation Compounds , 1995 .

[49]  W. Coetzee,et al.  KATP Channels in the Cardiovascular System. , 2016, Physiological reviews.

[50]  J. A. Peters,et al.  Transient receptor potential cation channels in disease. , 2007, Physiological reviews.

[51]  Martin Coleman Martin Coleman replies to “The place of technology education in the National Curriculum” , 1999 .

[52]  T. Strassmaier,et al.  The pharmacology of cyclic nucleotide-gated channels: emerging from the darkness. , 2006, Current pharmaceutical design.

[53]  Bernd Nilius,et al.  The vanilloid transient receptor potential channel TRPV4: from structure to disease. , 2010, Progress in biophysics and molecular biology.

[54]  L. Salkoff,et al.  High-conductance potassium channels of the SLO family , 2006, Nature Reviews Neuroscience.

[55]  Alistair Mathie,et al.  Therapeutic potential of neuronal two-pore domain potassium-channel modulators. , 2007, Current opinion in investigational drugs.

[56]  Mehrdad Payandeh Grundrechtsschutz im öffentlichen Kommunikationsraum , 2011 .

[57]  Bernd Nilius,et al.  Pharmacology of Vanilloid Transient Receptor Potential Cation Channels , 2009, Molecular Pharmacology.

[58]  D. Jane,et al.  Small conductance calcium-activated potassium channels: From structure to function , 2010, Progress in Neurobiology.

[59]  D. Zeevi,et al.  TRPML and lysosomal function. , 2007, Biochimica et biophysica acta.

[60]  L. Runnels,et al.  TRPM6 and TRPM7: A Mul-TRP-PLIK-cation of channel functions. , 2011, Current pharmaceutical biotechnology.

[61]  David E. Clapham,et al.  International Union of Pharmacology. L. Nomenclature and Structure-Function Relationships of CatSper and Two-Pore Channels , 2005, Pharmacological Reviews.

[62]  Yuriy Kirichok,et al.  The role of Hv1 and CatSper channels in sperm activation , 2010, The Journal of physiology.

[63]  David E. Clapham,et al.  mTOR Regulates Lysosomal ATP-Sensitive Two-Pore Na+ Channels to Adapt to Metabolic State , 2013, Cell.

[64]  Tibor Rohacs,et al.  Phosphoinositide regulation of non-canonical transient receptor potential channels. , 2009, Cell calcium.

[65]  Henry A. Lester,et al.  International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channels. , 2003, Pharmacological reviews.

[66]  C. Heurteaux,et al.  Targeting two‐pore domain K+ channels TREK‐1 and TASK‐3 for the treatment of depression: a new therapeutic concept , 2015, British journal of pharmacology.

[67]  Ming Xu,et al.  Animal Models in Studying Cerebral Arteriovenous Malformation , 2015, BioMed research international.

[68]  Michael A. Rogawski,et al.  Molecular targets for antiepileptic drug development , 2011, Neurotherapeutics.

[69]  Hiroshi Ueda,et al.  TRPM1: a vertebrate TRP channel responsible for retinal ON bipolar function. , 2010, Cell calcium.

[70]  Hiroaki Yamamoto,et al.  Integrated interpretation of well logs and surface seismic , 2001 .

[71]  Bernd Nilius,et al.  Permeation and selectivity of TRP channels. , 2006, Annual review of physiology.

[72]  O. Pongs,et al.  Ancillary subunits associated with voltage-dependent K+ channels. , 2010, Physiological reviews.

[73]  K Lawson,et al.  Modulation of potassium channels as a therapeutic approach. , 2006, Current pharmaceutical design.

[74]  R. Lathe Phd by thesis , 1988, Nature.

[75]  C. Wahl-Schott,et al.  Hyperpolarization-activated cation channels: from genes to function. , 2009, Physiological reviews.

[76]  Chunlei Cang,et al.  The voltage-gated sodium channel TPC1 confers endolysosomal excitability. , 2014, Nature chemical biology.

[77]  Bernd Nilius,et al.  TRP Channels in Disease , 2005, Science's STKE.

[78]  J. González-Ros,et al.  Towards understanding the molecular basis of ion channel modulation by lipids: Mechanistic models and current paradigms. , 2017, Biochimica et biophysica acta. Biomembranes.

[79]  U Benjamin Kaupp,et al.  Cooperative and uncooperative cyclic-nucleotide-gated ion channels. , 2011, Trends in biochemical sciences.

[80]  Karol Bal HEGEL UND POLEN , 2008 .

[81]  Michael X. Zhu,et al.  TPC Proteins Are Phosphoinositide- Activated Sodium-Selective Ion Channels in Endosomes and Lysosomes , 2012, Cell.

[82]  C. Wahl-Schott,et al.  HCN channels: Structure, cellular regulation and physiological function , 2009, Cellular and Molecular Life Sciences.

[83]  Laurent Sallé,et al.  The non-selective monovalent cationic channels TRPM4 and TRPM5. , 2011, Advances in experimental medicine and biology.

[84]  Dejian Ren,et al.  Calcium signaling through CatSper channels in mammalian fertilization. , 2010, Physiology.

[85]  S. Moss,et al.  G Protein-Gated Potassium Channels: A Link to Drug Addiction. , 2017, Trends in pharmacological sciences.

[86]  Raimund Mannhold,et al.  Structure-activity relationships of K(ATP) channel openers. , 2006, Current topics in medicinal chemistry.

[87]  W. Martin,et al.  AGONISTS AND ANTAGONISTS , 2006 .

[88]  Dario DiFrancesco,et al.  HCN-related channelopathies , 2010, Pflügers Archiv - European Journal of Physiology.

[89]  Naoto Hoshi,et al.  Modulation of Kv7 channels and excitability in the brain , 2016, Cellular and Molecular Life Sciences.

[90]  Yoshihiro Kubo,et al.  International Union of Pharmacology. LIV. Nomenclature and Molecular Relationships of Inwardly Rectifying Potassium Channels , 2005, Pharmacological Reviews.

[91]  A. Dubin,et al.  HCN channels as targets for drug discovery. , 2009, Combinatorial chemistry & high throughput screening.

[92]  Wendy M. Knowlton,et al.  TRPM8: from cold to cancer, peppermint to pain. , 2011, Current pharmaceutical biotechnology.

[93]  Xibao Liu,et al.  Contribution of TRPC1 and Orai1 to Ca(2+) entry activated by store depletion. , 2011, Advances in experimental medicine and biology.

[94]  Bernd Nilius,et al.  Store-Operated Ca2+ Entry Channels: Still Elusive! , 2004, Science's STKE.

[95]  F. Lesage,et al.  Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target? , 2016, Journal of medicinal chemistry.

[96]  Yi-Ling Cang,et al.  On certain univalent functions with missing coefficients , 2013 .

[97]  F. Lesage,et al.  The family of K2P channels: salient structural and functional properties , 2015, The Journal of physiology.

[98]  Bernd Nilius,et al.  Vanilloid transient receptor potential cation channels: an overview. , 2008, Current pharmaceutical design.

[99]  Philip Kraft,et al.  Synthesis and Olfactory Properties of Spirocyclic Georgywood® Analogues , 2006 .

[100]  Po-Cheng Chang,et al.  SK channels and ventricular arrhythmias in heart failure. , 2015, Trends in cardiovascular medicine.

[101]  Jean-Claude Tardif Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases. , 2008, Drugs of today.

[102]  Leonard K. Kaczmarek,et al.  International Union of Basic and Clinical Pharmacology. C. Nomenclature and Properties of Calcium-Activated and Sodium-Activated Potassium Channels , 2017, Pharmacological Reviews.

[103]  Yi Liu,et al.  TRPM8 in health and disease: cold sensing and beyond. , 2011, Advances in experimental medicine and biology.

[104]  Pierangelo Geppetti,et al.  Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents. , 2010, Journal of medicinal chemistry.

[105]  R. Aldrich,et al.  International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. , 2005, Pharmacological reviews.

[106]  Kai-Chien Yang,et al.  Mechanisms contributing to myocardial potassium channel diversity, regulation and remodeling. , 2016, Trends in cardiovascular medicine.

[107]  C. Bever,et al.  Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. , 2006, Pharmacology & therapeutics.

[108]  Christopher Southan,et al.  The Concise Guide to PHARMACOLOGY 2015/16: Voltage‐gated ion channels , 2015, British journal of pharmacology.

[109]  Dario DiFrancesco,et al.  Cycling in the Mechanism of Pacemaking Cardiac Pacemaking : Historical Overview and Future Directions , 2010 .

[110]  David E. Clapham,et al.  International Union of Basic and Clinical Pharmacology. LXXVI. Current Progress in the Mammalian TRP Ion Channel Family , 2010, Pharmacological Reviews.

[111]  Susanne Rinné,et al.  Stretch-activated potassium currents in the heart: Focus on TREK-1 and arrhythmias. , 2017, Progress in biophysics and molecular biology.

[112]  F. Viana,et al.  The emerging pharmacology of TRPM8 channels: hidden therapeutic potential underneath a cold surface. , 2011, Current pharmaceutical biotechnology.

[113]  M. Islam,et al.  TRP channels of islets. , 2011, Advances in experimental medicine and biology.

[114]  Koji Nagata,et al.  Additional information decreases the estimated entanglement using the Jaynes principle , 2008, 0801.1944.

[115]  Hisashi Yamamoto,et al.  A New Scandium Complex as an Extremely Active Acylation Catalyst , 1996 .